Amidst the continued struggle to treat non-small-cell lung cancer, a new study led by Stanford University scientists suggests that a patient's response to immunotherapy may hinge on how immune cells ...

An artificial intelligence technique for detecting DNA fragments shed by tumors and circulating in a patient's blood could help clinicians more quickly identify and determine if pancreatic cancer ...

As cancer continues to pose a growing public health concern, Ameera Shah-led Metropolis Healthcare Limited, India’s ...

An international group of scientists has identified a key molecular process that drives a deadly form of childhood brain ...

A new risk assessment score developed by researchers at Dana-Farber Cancer Institute and the Broad Institute of MIT and Harvard reveals how multiple myeloma, a form of blood cancer, begins and ...

When the doctor utters the word “cancer” one might immediately go numb as their mind takes a minute to comprehend the ...

Tumor marker levels were measured prior to treatment ... For patients from Santa Casa de Misericórdia, the samples were collected by the institution laboratory, and the following marker level values ...

Backed by well-established scientific literature, these LMI-lab tumor markers provide enhanced sensitivity for several high-risk cancers. Patients benefit from improved detection of prostate ...

Everyone produces different levels of tumor markers, which makes it difficult to determine diagnostic cut-off values. Laboratory testing techniques may vary, which may impact the reliability of ...

Some cancers are fairly treatable, while others are much more difficult to target. Fortunately, primary tumor growth can be controlled, however, tumor expansion (also known as metastasis) to other ...

This is commonly referred to as “marker,” “tumor marker,” or “biomarker” testing by physicians ... doctor removed small pieces of breast tissue to be looked at in the lab. “During this initial biopsy, ...